-
Business
-
Policy & Business
-
-
Federal IT
-
Information Technology
-
-
State & Local
-
State & Local Government
-
-
Defense
-
Defense & Intelligence
-
-
Healthcare
-
Healthcare Policy & IT
-
-
Energy
-
Energy Policy & Technology
-
-
Education
-
Education Policy & Technology
-
Drug for Bioterrorism Antimicrobial Resistant Infections Funded by HHS
Homeland Security Today: A new drug that is expected to help protect the public against two bioterrorism threats will advance in development under a public-private partnership, the Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) announced.
Tags
Share
Top Stories
- After Stonewalling Claims, Biden Team to Consult with Top Generals Overseas
- Aircraft carrier Nimitz staying in Mideast as Iran raises uranium enrichment levels, seizes South Korean ship
- Five top challenges for Biden on defense
- New in 2021: Confirmation timing for new DoD, VA secretaries could be tricky
- Trump administration declassifies unconfirmed intelligence on China bounties on US forces in Afghanistan: report
- Defense Secretaries Worried About a Trump Power Grab
- DC National Guard activated for pro-Trump protests as mayor urges calm
- Senate Joins House in Overriding Trump’s Veto of Defense Bill
- New in 2021: Bonhomme Richard will be turned into scrap
- For Pentagon, Biden Picks Two Obama-era Policy Veterans to Help Austin
- Row explodes between Pentagon, Biden transition team
- Insurance changes could help disabled veterans, troops in the new year
- Top US general meets with Taliban negotiators
- Trump repeats his vow to veto the defense budget bill, but won’t say when
- US hits alleged Iran-backed Bahrain group with sanctions
- Big six veterans groups ask Trump to fire VA Secretary Wilkie immediately
Whitepapers & Special Reports
i360Gov Newsletters
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe NowAlso in Defense & Intelligence
About
i360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Contact Us
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
Newsletters
Copyright © 2009-2025 i360Communications, LLC.